Translocation Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Translocation Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC) [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study evaluating the combination of abemaciclib and cabozantinib in metastatic renal cell c…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 clinical trial update for a combination of sasanlimab, palbociclib, and axitinib in metastatic renal cell carcinoma; currently recru…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma [EARLY_Phase 1]
This early-phase trial is evaluating memory-like natural killer (NK) cell therapy in patients with renal cell carcinoma and urothelial carci…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC [Phase 2]
Phase 2 clinical trial update evaluating cabozantinib in combination with nivolumab and ipilimumab for advanced non-clear cell renal cell ca…